BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17957724)

  • 1. Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells.
    Ohta S; Lai EW; Morris JC; Pang AL; Watanabe M; Yazawa H; Zhang R; Green JE; Chan WY; Sirajuddin P; Taniguchi S; Powers JF; Tischler AS; Pacak K
    Mol Carcinog; 2008 Apr; 47(4):245-51. PubMed ID: 17957724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile.
    Powers JF; Evinger MJ; Zhi J; Picard KL; Tischler AS
    Neuroscience; 2007 Jul; 147(4):928-37. PubMed ID: 17582688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature.
    Martiniova L; Lai EW; Elkahloun AG; Abu-Asab M; Wickremasinghe A; Solis DC; Perera SM; Huynh TT; Lubensky IA; Tischler AS; Kvetnansky R; Alesci S; Morris JC; Pacak K
    Clin Exp Metastasis; 2009; 26(3):239-50. PubMed ID: 19169894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy.
    Thouënnon E; Elkahloun AG; Guillemot J; Gimenez-Roqueplo AP; Bertherat J; Pierre A; Ghzili H; Grumolato L; Muresan M; Klein M; Lefebvre H; Ouafik L; Vaudry H; Plouin PF; Yon L; Anouar Y
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4865-72. PubMed ID: 17878247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of rat pheochromocytoma.
    Elkahloun AG; Powers JF; Nyska A; Eisenhofer G; Tischler AS
    Ann N Y Acad Sci; 2006 Aug; 1073():290-9. PubMed ID: 17102098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique allogenic model of metastatic pheochromocytoma: PC12 rat pheochromocytoma xenografts to nude mice and establishment of metastases-derived PC12 variants.
    Zielke A; Bresalier RS; Siperstein AE; Clark OH; Rothmund M; Duh QY
    Clin Exp Metastasis; 1998 May; 16(4):341-52. PubMed ID: 9626813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging.
    Giubellino A; Woldemichael GM; Sourbier C; Lizak MJ; Powers JF; Tischler AS; Pacak K
    Cancer Lett; 2012 Mar; 316(1):46-52. PubMed ID: 22154086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-specific metastatic phenotypes in pheochromocytoma allograft mice.
    Ullrich M; Liers J; Peitzsch M; Feldmann A; Bergmann R; Sommer U; Richter S; Bornstein SR; Bachmann M; Eisenhofer G; Ziegler CG; Pietzsch J
    Endocr Relat Cancer; 2018 Oct; 25(12):993-1004. PubMed ID: 30288966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stathmin as a marker for malignancy in pheochromocytomas.
    Björklund P; Cupisti K; Fryknäs M; Isaksson A; Willenberg HS; Akerström G; Hellman P; Westin G
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):27-30. PubMed ID: 19449284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling.
    Suh I; Shibru D; Eisenhofer G; Pacak K; Duh QY; Clark OH; Kebebew E
    Ann Surg; 2009 Dec; 250(6):983-90. PubMed ID: 19661783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
    Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
    Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.
    Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
    Endocr Relat Cancer; 2014 Jun; 21(3):495-504. PubMed ID: 24741025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
    Guillemot J; Thouënnon E; Guérin M; Vallet-Erdtmann V; Ravni A; Montéro-Hadjadje M; Lefebvre H; Klein M; Muresan M; Seidah NG; Anouar Y; Yon L
    J Mol Endocrinol; 2012 Apr; 48(2):115-27. PubMed ID: 22217803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray analysis reveals differential expression of benign and malignant pheochromocytoma.
    Waldmann J; Fendrich V; Holler J; Buchholz M; Heinmöller E; Langer P; Ramaswamy A; Samans B; Walz MK; Rothmund M; Bartsch DK; Slater EP
    Endocr Relat Cancer; 2010 Sep; 17(3):743-56. PubMed ID: 20562231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
    Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
    Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray-based comparative genomic hybridization of pheochromocytoma cell lines from neurofibromatosis knockout mice reveals genetic alterations similar to those in human pheochromocytomas.
    Powers JF; Tischler AS; Mohammed M; Naeem R
    Cancer Genet Cytogenet; 2005 May; 159(1):27-31. PubMed ID: 15860353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
    Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.
    Amar L; Baudin E; Burnichon N; Peyrard S; Silvera S; Bertherat J; Bertagna X; Schlumberger M; Jeunemaitre X; Gimenez-Roqueplo AP; Plouin PF
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3822-8. PubMed ID: 17652212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.